AG Ford launches bid for Nevada governor
Nevada Attorney General Aaron Ford formally launched his 2026 campaign for governor Monday against Republican Gov. Joe Lombardo....
States file lawsuit against Trump administration over efforts to collect SNAP recipients’ data
By KIMBERLY KINDY Associated Press Washington (AP) — A coalition of 20 state attorneys general filed a lawsuit Monday challenging the Trump administ...
Ken Paxton sues New York county clerk over abortion ruling
Texas Attorney General Ken Paxton is filing a petition against a New York county clerk regarding an abortion ruling....
Federal cuts may result in 140,000 Minnesotans losing health coverage
The Minnesota Department of Human Services says up to 140,000 Minnesotans could lose health care coverage due to federal Medicaid spending cuts....
CocaCola Company (The) (NYSE:KO) Receives Average Recommendation of “Buy” from Brokerages
Shares of CocaCola Company (The) (NYSE:KO – Get Free Report) have received an average rating of “Buy” from the seventeen brokerages that are pre...
‘It just doesn’t seem fair’: Clarendon Courtyard patios to close early due to NCC construction
Restaurants must clear their patios from the Clarendon Courtyard to make way for NCC construction expected to begin on Aug. 11...
Jim Cramer on why the market put tariff deals on the back burner
'Mad Money' host Jim Cramer explains why the EU tariff announcement did not do much to move the market today....
FDA Approves Apellis' EMPAVELI® (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older
Proven efficacy across all three key markers of disease—68% reduction in proteinuria, stabilization of kidney function, and substantial clearance of...
Second Regional Webinar with PAHO/WHO Collaborating Centres - Pan American Health Organization (PAHO)
Second Regional Webinar with PAHO/WHO Collaborating Centres Pan American Health Organization (PAHO)...
FDA Approves Apellis’ EMPAVELI® (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older
WALTHAM, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the U.S. Food and Drug Administrat...
This malady affects millions but is not well understood - Deseret News
This malady affects millions but is not well understood Deseret News‘Supermicrosurgery’ offers path to preventing lymphedema in breast cancer pati...
